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CHAPTER 1: INTRODUCTION 
1.1 EMBRYOGENESIS 
From a fertilized egg to a multi-cellular adult, embryogenesis is an intricate process 
that determines the fate of an organism. Xenopus laevis (X. laevis) is one of the leading 
model systems for vertebrate phenotypic and molecular experimentation, ranging from 
the determination of gene expression patterns at different stages to determining protein-
protein interaction.1 X. laevis offers the ease of acquisition of numerous eggs as well as 
the ease of manipulation and fertilization of these eggs due to their large size (1mm). 
Post-harvest, introduction of DNA, RNA, or proteins to target molecular pathways 
requires relatively simple microinjection techniques. Observation of many developmental 
stages can also be performed relatively efficiently because X. laevis embryos undergo fast 
cellular division. Most importantly, X. laevis and vertebrate developmental pathways are 
often evolutionarily conserved, making findings in the frog model system potentially 
useful for clinical therapeutics. 
Fertilization of the X. laevis egg initiates two crucial events that establish the dorsal 
and ventral axes.2 One of these two events, cortical rotation, promotes the displacement 
of dorsalizing factors at the vegetal cortex to about 30° from their original position. The 
factors are displaced opposite to sperm entry and mark the future dorsal region.2 
Preceding cortical rotation is the proper arrangement and polymerization of microtubules 
(MT). In fact, studies have shown that dorsoanterior structures are unable to form due to 
lack of cortical rotation when the MT are improperly positioned.2 The blastula stage 
follows fertilization, with rapid cell division occurring to form a hollow ball of cells in 
preparation for gastrulation. 
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One of the most important events of embryogenesis is gastrulation, during which the 
cells of an embryo arrange themselves into three germ layers – endoderm, mesoderm, and 
ectoderm. This is fundamental not only for organogenesis but also in promoting specific 
movements of cells that pattern the embryo to its adult form. Tracking the later 
development of these germ layers has shown that the endoderm differentiates into 
endothelial cells, which line the organs of the digestive system such as the intestines and 
stomach.3 The mesoderm matures into somatic and mesenchymal cells, which eventually 
form organs in the circulatory, reproductive and muscular systems, to name a few.4,5 
Furthermore, the notochord, which is of special interest to my research, is mesodermally 
derived.6 Lastly the ectodermal layer forms the nervous and integumentary systems, 
which include organs such as the spine, nerves, brain, and skin.7  
Each of the germ layers possesses unique cellular movement and signaling properties. 
The Xenopus embryo undergoes cellular differentiation and drastic rearrangement during 
gastrulation, and the cell movements directing this can be summarized into three 
categories: involution, epiboly, and convergent extension. Because cellular 
rearrangement heavily relies on specific cell adhesion and cell-cell directed signals, 
proper germ layer differentiation is crucial to this operation. The three cellular 
movements lead to the correct positioning of the germ layers in the embryo, with the 
mesoderm lying between the superficial ectoderm and deep endoderm. Involution allows 
prospective mesoderm cells to be internalized between the ectoderm and endoderm 
preceding the occurrence of axial patterning and neurulation, which is the initial 
formation of the nervous system. In this process, cells around the blastopore that are 
destined to be the mesoderm exert a tension on each other that makes them collectively 
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migrate within the embryo. At the same time, the blastopore decreases in size until it 
closes at the end of gastrulation. One hypothesis that I will later present regarding 
blastopore closure is that the mesoderm cells surrounding the blastopore interact with 
each other to collectively form a structure much like the opening of a stringed coin purse. 
As with the coin purse, the continuous tension created by the cells amongst themselves 
help facilitate blastopore closure as the mesoderm involutes. The mesoderm-specific 
marker brachyury is often used to visualize this group of cells as it shows a clear, ring-
like staining surrounding the blastopore.8,9 
Concurrent with involution, the dividing, multi-layered cells in the animal pole 
undergo epiboly to actively spread and thin-out over the animal region of the embryo.10 
This rearrangement of cells helps facilitate involution of the bottle cells, located at the 
DMZ (dorsal marginal zone), into the blastopore.11 In consequence, the prospective 
mesendoderm is able to locate itself under the ectodermal layer. Furthermore, the 
rearrangement of cells covers that body as cells move dorsolaterally. 
Convergent extension (CE), in which lateral cells converge and intercalate to the 
dorsal midline region to anteroposteriorly extend the body axis of the embryo, 
concurrently occurs with epiboly and involution during gastrulation and is of special 
interest to my experiments. Studies conducted in zebrafish and Xenopus revealed that 
MIB (mediolateral intercalation behavior) is a complex and coordinated movement that 
helps cells to move mediolaterally and then longitudinally to produce a collective 
convergent extension cell mobility.12,13 Figure 1.1 shows that CE not only results in the 
lengthening of the anterior-posterior axis but it is also indispensible to the neurulation 
stage as it helps “zip” the mesodermally derived notochord.12,13  
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Though the three cellular movements are often studied separately, it must be stressed 
that they are, in reality, concurrent. For example, normal notochord formation is 
continuous with blastopore closure in that anterior to posterior convergence extension 
occurs as mesodermal cells involute and settle themselves under the ectodermal layer, 
highlighting the concurrence of these two cellular movements during gastrulation. 
      Control MO       Zic3 SS MO 
 
!
A B 
C D 
 
 
Figure 1.1 The role of convergent extension and blastopore closure on notochord 
formation. (A, B, C, D) The Xbra expression pattern of Zic3-depleted embryos suggests 
that blastopore closure is essential for convergent extension and thus for the development 
of the mesodermally-derived notochord. This experiment utilized morpholinos (MO), 
which are anti-sense oligonucleotides that bind to the sense strand of an RNA to reduce 
gene translation. (A, B) The MO-injected embryo showed a darker staining of the pan-
mesodermal marker Xbra around the blastopore (dashed line) in contrast to wild-type, 
suggesting that mesoderm did not undergo convergent extension and remained around the 
blastopore. In addition, notochord formation was disrupted in the MO-injected embryos, 
suggesting that convergent extension was delayed. (C, D) As early neurulation proceeds 
the MO-injected embryo produces a wider and shorter notochord as opposed to the wild-
type.  (Adapted from Cast A.E. et al.) 14  
 
1.2 TRANSFORMING GROWTH FACTOR-β FAMILY 
The TGF-α and TGF-β proteins were the first two members of the TGF-β 
superfamily to be identified.15 They were discovered in adult mouse non-neoplastic 
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tissues as an influence on the anchorage-independent growth of cells in concert with 
epidermal growth factor.16 The identification of other members of the superfamily 
followed, including the BMPs (Bone Morphogenetic Proteins), GDFs (Growth and 
Differentiation Factors), Activins, and Nodal. Since their discovery, they have been 
shown to regulate a vast number of cellular functions that influence, among other things, 
two very important biological events-embryogenesis and oncogenesis.17,18 
The TGF-β and the Wnt signaling pathway, among other biological pathways, 
regulate cellular differentiation and mobility during gastrulation.18,19 Previous studies of 
the TGF-β ligand Nodal showed that proper differentiation of cells into mesoderm is 
crucial to the production of the continuous intracellular tension exerted by the blastopore 
cells, which is indispensable to blastopore closure.20,21 Failure of blastopore closure leads 
to a phenotype we describe as “open-back” as well as an aberrant, shortened notochord.  
1.2.A STUCTURE AND SIGNALING 
 The TGF-β superfamily genes encode proproteins that contain an N-terminal 
prodomain, a cleavage sequence, and an active domain at the C-terminus.22 These ligands 
contain disulfide bonds that form a cysteine knot that facilitates dimerization for 
signaling and processing.23 Both homo- and heterodimerization occurs between the 
members of the superfamily.17 For example, Nodal can interact with BMP4 or BMP7, but 
can also signal as a homodimer during gastrulation.24 Generally, TGF-β precursor 
proteins undergo folding and dimerization, followed by cleavage by Subtilisin-like 
Proprotein Convertases (SPCs) to release the mature dimer, which is able to elicit 
biological activity.25 The necessity of proprotein cleavage is underscored in previous 
findings that showed disrupted or lack of function of the unprocessed protein. In mouse 
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Nodal, mutation of the recognition site of Furin, an SPC, leads to the perturbation of its 
signaling capability, suggesting that protein processing through cleavage of the 
prodomain is critical for its biological activity.26 Moreover, Lefty, an atypical TGF-β and 
a Nodal inhibitor, requires the cleavage of its prodomain to be able to block Nodal.27,28 
Another way that TGF-β ligands are regulated is through extracellular sequestration by 
distinct ligand-binding proteins. Chordin/Short gastrulation (Sog), Noggin, and Follistatin 
are some examples of such molecules that bind BMPs and GDFs.29 This sequestration 
ultimately sets concentration gradients that are important in developmental events such as 
determining cell fates. 
 TGF-β members signal through specific type I and type II serine/threonine kinase 
receptors, ultimately forming a complex of ligand and receptors.30,31 A TGF-β ligand 
dimer binds to the type II receptor that is constitutively active and this interaction recruits 
and activates the type I receptor through phosphorylation. The signal is then carried to the 
nucleus as the type I receptor phosphorylates regulatory Smads (R-Smads) that are 
specific to each TGF-β ligand signaling pathway. The phosphorylated R-Smad together 
with Smad 4 then translocate to the nucleus and interact with transcription factors to 
regulate the expression of target genes. Although TGF-βs share a general structure and 
components in their signaling pathway, the vast number of combinations between 
ligands, receptors, Smads, and transcriptional effectors not only result in signaling 
specificity but also a diversity in output. 
I.2.B NODAL SIGNALING PATHWAY  
First discovered in mouse, Nodal homologues have since been characterized in 
humans, Xenopus, zebrafish, and many other model organisms. Mouse and humans have 
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only one Nodal, zebrafish has three - cyclops (cyc), squint (sqt), and southpaw (spw) - 
and six are present in Xenopus – Xnr (Xenopus Nodal-related) 1-6.32-35 The Nodal 
signaling pathway follows the typical signal transduction of TGF- βs. As a homodimer 
Nodal binds to the constitutively active type II receptor ActRIIB, which then activates 
type I receptor ALK4/7 through phosphorylation as a ligand-receptor complex forms 
(Figure 1.2 I). At the heart of this interaction is the obligate EGF-CFC co-receptor Cripto. 
The EGF-CFC (epidermal growth factor – Cripto 1/FRL-1/Cryptic) protein contains an 
EGF domain that binds Nodal and a CFC domain that binds ALK4, ultimately stabilizing 
the complex. Studies done in zebrafish demonstrated the necessity of Cripto, as Nodal 
homologues cyc and sqt were unable to signal with mutant oep, a homologue of Cripto.36 
From the ligand-receptor complex, the Nodal signal is transduced via the phosphorylation 
of Smad2/3 by the type I receptor. Then Smad2/3 interacts with Smad4 and translocate 
into the nucleus (Figure 1.2 I). In the nucleus, the Smads interact with transcription 
factors such as FoxHI (Forkhead box HI) and Mixer to activate Nodal-dependent genes, 
such as those that promote cell differentiation to mesoderm and endoderm. Furthermore, 
the signaling cascade creates a positive feedback loop that increases Nodal expression, 
and it also promotes the transcription of its inhibitor, Lefty, allowing for further 
autoregulation of signaling (Figure 1.2 II).  
One of the key characteristics of Nodal is its ability to signal as a morphogen 
(Figure 1.2 II). At the beginning of vertebrate embryogenesis, germ layer specification is 
achieved based on the amount of Nodal signaling that sheets of cells receive. Those that 
are exposed to the highest level of Nodal differentiate into endoderm, while a relatively 
lower level leads to mesodermal specification. Nodal has also been shown to regulate 
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neuroectoderm via the suppression of its signaling, thereby highlighting its importance 
for the development of all the three layers.37 Germ layer cells then further differentiate 
into organs as the embryo proceeds to mature into an adult.  
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as they lack the canonical cysteine residue that
stabilizes TGFβ dimers [2,5]. However, Chen and Shen
[11] found that Lefty and Nodal can directly interact in
solution, revealing a second potential mechanism of
Lefty-dependent Nodal antagonism. This interaction
likely antagonizes Nodal signaling by preventing Nodal
from binding its receptor complex (Figure 1C,D), as evi-
denced by the ability of Lefty to abrogate the co-
immunoprecipitation of Nodal with the type II receptor
[11]. Alternatively, Lefty–Nodal interactions might affect
the endoproteolytic processing of Nodal and subse-
quently impact Nodal activity.
Many studies have suggested that Lefty can
antagonize TGFβ signaling pathways other than
Nodal. The ability of Lefty to inhibit Vg1/GDF, but not
Activin or TGFβ1, signaling was discussed above.
Lefty has also been implicated in BMP signaling
[3,7,10]. In light of the discovery of Lefty–Nodal
interaction, can Lefty biochemically interact with
Vg1/GDFs, BMPs or itself? If so, how will these
interactions affect signaling? The identification of the
domains in Nodal and the EGF-CFCs necessary for
Lefty binding will allow the ‘in silico’ selection of other
candidates for Lefty interaction.
Dispatch
R342
Figure 1. Direct interaction of Lefty with
EGF-CFCs and Nodal antagonizes Nodal
signaling. 
(A) Nodal signaling is an EGF-CFC-depen-
dent process. The binding of Nodal by
EGF-CFC co-receptors facilitates the
interaction of Nodal and the type I–type II
Nodal receptor complex. This extracellular
interaction leads to the Smad-dependent
upregulation of Nodal response genes.
(B–D) Lefty inhibits Nodal signaling by pre-
venting the association of Nodal with the
type I–type II receptor complex. This inhi-
bition results from the direct interaction of
Lefty with the EGF-CFC co-receptor (B,C)
or with Nodal (C,D). Additionally, both
Lefty and EGF-CFCs can activate MAP
kinase signaling, suggesting a possible
role for Lefty–EGF-CFC interactions in this
process (B,C). For simplicity, Lefty and
Nodal are depicted as monomers.
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MAPK
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EGF-CFC
Lefty
A
C
D
B
Response genes
Current Biology
Figure 2. Lefty–Nodal reaction–diffusion
establishes Nodal signaling gradients.
The Turing reaction–diffusion model
hypothesizes that interactions between an
activator and an inhibitor control signaling
gradients within a field of cells and sub-
sequently pattern them. Nodal–Lefty inter-
actions exemplify several aspects of this
model [1,17]. First, the activator (Nodal)
activates its own production. Second, the
activator (Nodal) activates its inhibitor
(Lefty). Third, the inhibitor (Lefty) blocks
activator (Nodal) autoactivation. Fourth,
the inhibitor (Lefty) acts at a distance to
restrict the effective range of the activator
(Nodal). (A) Schematic illustration of
Lefty–Nodal reaction–diffusion. The black
squares represent a field of cells within a
Nodal-signaling gradient. The left-most
cell is the Nodal/Lefty point source, and
the first three properties of Nodal–Lefty
reaction–diffusion are depicted within.
The red lines and bars emanating from
this cell depict the fourth property, the
long-range activity of Lefty. The green
lines and arrows depict Nodal signaling.
Note that Lefty is depicted to act farther
from its source than Nodal [2,17]. Nearest to the point source, Nodal concentrations predominate over those of Lefty, resulting in high-
level Nodal signaling. Farther from the source, the ratios of Lefty to Nodal increase and result in low-level Nodal signaling. Farthest
from the source, Lefty concentrations predominate and effectively inhibit Nodal signaling. (B) Graphic depiction of the Nodal (green
line) and Lefty (red line) concentration gradients in A.
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Figure 1.2 The Nodal signaling pathw y. I. The N dal lig nd utilizes serine/threonine 
receptor kinases to transduce its signal. (IA) Nodal binds to the constitutively active type 
II receptor, which results in the activation of the type I receptor by phosphorylation. 
Stabilizing this receptor-liga d interaction is the GPI-linked obligate co-receptor Cripto. 
Smad2/3 are then phosphorylated and bind to Smad4. This complex translocates into the 
nucleus to activate transcription factors. This signaling cascade promotes a positive 
feedback loop for Nodal expression as well as the expression of its inhibitor Lefty. (I B, 
C, D) To negatively regulate Nodal, Lefty either binds to Cripto, forms a complex with 
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Nodal and Cripto to prevent them from interacting with the receptor complex, or binds 
Nodal to prevent it from accessing Cripto and the type I/II complex. 
II. Nodal forms a concentration gradient through a field of cells. (A) At the point of 
origin, Nodal positively regulates its own transcription as well as promotes the 
transcription of its inhibitor Lefty. The signaling cascade then occurs in a field of 
neighboring cells but in tapering strength as the availability of unused ligand decreases as 
the distance from the origin increases. Also, Lefty travels faster than Nodal. (B) shows 
signaling effectiveness as Nodal and Lefty travel from their point source. Nodal signaling 
is highest at its origin and gradually decreases as it travels away. This gradation is 
especially important in early development as germ layers differentiate according to the 
amount of Nodal signaling they receive. (Adapted from Branford W.W. and Yost H.J.)38 
 
1.3 LEFTY: A REGULATOR OF THE NODAL SIGNALING PATHWAY 
Due to its importance during gastrulation the Nodal signaling pathway requires 
tight regulation. In fact, it relies on negative feedback inhibition by promoting the 
expression of its own important inhibitor, Lefty, which is itself an atypical TGF-β. 
Translated as a proprotein, Lefty requires cleavage by SPC convertases at its two RXXR 
consensus cleavage sites.39 In contrast to other TGF-βs, Lefty acts as an inhibitor rather 
than a signaling ligand. Furthermore, it lacks the cysteine residues that allow the 
dimerization that other TGF-βs members undergo.40 Because Lefty has two cleavage 
sites, a long and short form of the protein is at times produced post-processing.28 The 
interest of our lab is to examine the functions of the protein domains of Xlefty (Xenopus 
Lefty). We know that the TGF-β Xlefty relies on the release of the prodomain by 
cleavage at its first RXXR site (site 1) to gain the ability to block Nodal signaling.28 In 
contrast to site 1, the biological relevance of the second cleavage site (site 2) is still 
unclear. In addition to Nodal, Lefty also prevents the signaling of the TGF-β ligands 
Vg1/GDF1 and GDF3, both of which require Cripto for signaling.41-44  
There are two ways that Lefty has been shown to prevent Nodal signaling. One is 
by competitively binding to the EGF-CFC protein Cripto, thereby preventing Nodal from 
  
11 
forming a complex with its obligate co-receptor and ultimately halting the pathway. 
Alternatively, it has been shown that Lefty and Nodal can interact directly, preventing 
Nodal from signaling through its receptors.45-47 This is interesting and unexpected since it 
lacks the cysteine residues that are crucial for homo- or heterodimerization in other TGF-
βs, yet it was able to bind Nodal in mammalian cell culture.45  
Because Nodal acts at a distance, Lefty needs to effectively inhibit the Nodal 
signaling by being able to travel through cells as well. When mouse Nodal and Lefty 
were each tagged with GFP and expressed in chick embryos, both proteins traveled away 
from the site of expression and Lefty diffused further than Nodal.40 Further support for 
the diffusion of Lefty and Nodal was found in zebrafish studies using photobleaching.48,49 
Lefty and Nodal are believed to be an example of the Turing reaction-diffusion model in 
which a signaling gradient is created by the interaction of the activator Nodal and 
inhibitor Lefty to pattern a field of cells (Figure 1.2II). The balance between Lefty and 
Nodal that this model proposes is essential during gastrulation because cells differentiate 
according to the amount of Nodal signaling they receive as regulated by Lefty, with the 
mesendoderm receiving the most and the ectoderm the least Nodal signaling. The left-
right axis patterning of the embryo also utilizes the Turing model as Nodal and Lefty 
originate at the left lateral plate mesoderm; however, the inhibitor Lefty diffuses longer 
and faster to slightly beyond the midline to inhibit the expression of the activator in the 
right lateral plate mesoderm and to diminish the Nodal signaling proportional to its 
origin.49 The asymmetry formed during this event is utilized in organogenesis as a 
number of organs such as the liver, heart, and intestines exhibit left-right asymmetry. 
Specifically, the heart slightly orients itself to the left side of the body and the gut coils 
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counter-clockwise. In this sense, the Nodal-Lefty interaction is not only responsible for 
the specification of the “raw materials” – the germ layers – but it also helps direct their 
correct positioning as they further differentiate in the adult body plan.  
The improper specification of germ layer identity by the Nodal signaling pathway 
during gastrulation can lead to various phenotypic aberrations in the adult species. For 
example, in mice an absence of Lefty leads to excess mesoderm and an expanded 
primitive streak because of increased Nodal signaling. In frogs, Lefty-deficient embryos 
fail to undergo involution, which results in inside-out embryos that underwent 
exogastrulation instead.50 In such case, excess mesendoderm is produced at the expense 
of a diminished ectoderm due to increased Nodal signaling. Excess Lefty, on the other 
hand, almost completely represses Nodal signaling and ultimately causes lethality due to 
a lack of mesendoderm, which disrupts gastrulation.41 The execution of key cellular 
movements during gastrulation relies on the presence of the three germ layers; thus, the 
interplay between Nodal and Lefty greatly influences multiple processes during early 
development.  
1.4 EPIDERMAL GROWTH FACTOR-CRIPTO, FRL-1, CRYPTIC (EGF-CFC) 
1.4.A STRUCTURE AND DISCOVERY 
 The EGF-CFC (epidermal growth factor – Cripto 1/FRL-1/Cryptic) protein family 
consists of glycosylphosphatidylinositol (GPI)-anchored signaling proteins that are 
indispensable to the normal progression of embryogenesis, regulating cellular migration, 
differentiation, and proliferation. The first EGF-CFC family member, human Cripto-1, 
was isolated from embryonal NTERA2 teratocarcinomal cells.51 Subsequently, many 
orthologs have been discovered, including mouse Cripto-1/cfc2 and Cryptic/cfc1; 
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zebrafish one-eyed pinhead (oep); Xenopus Cripto-like 1-3 (XCr1/FRL-1, XCr2, and 
XCr3); and human Cripto and Cryptic. 51-53 54,55  
Structurally, members of the EGF-CFC family have an N-terminal signal 
sequence, an EGF-like domain, a cysteine-rich CFC domain, and a hydrophobic C-
terminus that facilitates GPI-linkage (Figure 1.3). While all the proteins share some 
sequence identity within the EGF-like and CFC domains, they are dissimilar otherwise.  
Cripto is tethered to the cell membrane by GPI linkage, but a cleavage site recognized by 
GPI-phospholipase D also allows for the release of a soluble form.56 As a co-receptor for 
Nodal, Cripto is required to be GPI-bound; however, it can also function as a ligand in its 
soluble form.57 The EGF domain binds to Nodal while the CFC domain interacts with the 
type I receptor to stabilize ligand-receptor binding. Schiffer et al. have found that 
Cripto’s co-receptor ability rests on the O-fucosylation of its EGF-like domain, and 
mutation of the conserved fucosylation substrate Thr-88 to Ala within this region 
prevents Cripto from binding Nodal.58 On the other hand, studies done in mouse and 
zebrafish suggest that soluble Cripto is able to retain its biological activity despite its 
membrane release.59 In particular the Src, ras/raf/MAPK and PI3K/Akt pathways have 
been reported to be activated by secreted Cripto.56  
 
Figure 1.3 Cripto structure. Cripto contains a signal sequence at the N-terminus, an 
EGF-like domain, a CFC domain, and a C-terminal sequence for GPI linkage. The EGF 
domain has been shown to bind Nodal while the CFC interacts with the Nodal receptor 
ALK4. Nodal signaling relies on GPI-anchored Cripto. (Adapted from Gray, P.C. and Vale 
W.) 57 
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1.4.B CRIPTO AND TGF-β LIGANDS 
 One of the best-studied biological activities of EGF-CFCs is during development. 
In undifferentiated cells during early gastrulation, Cripto is highly expressed as it aids in 
germ layer specification, neurulation and organogenesis via its obligate role in Nodal 
signaling.24 Furin and PACE4 are SPC proprotein convertases that process Nodal 
cleavage and Cripto is necessary for their recruitment.60 During Nodal signal 
transduction, the EGF domain binds to Nodal ligand and stabilizes the ligand-ALK4 
receptor complex through the interaction of the CFC domain and ALK4.24 The co-
receptor capability of Cripto is specific to the insoluble form as a mutant Cripto lacking 
its GPI-linkage binds Nodal but is unable to mediate signaling.40  
Multiple studies have solidified the necessity of Cripto in Nodal signaling. For 
example, zebrafish embryos lacking functional maternal and zygotic Oep (MZoep) 
phenocopy those that are double mutant for the nodal-related genes squint and cyclops 
and exhibit cyclopia.36 Furthermore, attempted rescue of MZoep embryos using 
overexpression or misexpression of the Nodals was unsuccessful.36 Studies done in chick 
showed that Cripto seems to be the limiting factor in the Nodal-dependent formation of 
the IM (intermediate mesoderm) that gives rise to kidneys in that the increase of Cripto 
results in an expansion of the IM.61 These lines of evidence suggest the indispensability 
of EGF-CFC as a co-factor in Nodal signaling which establishes the mesoendodermal 
germ layers.  
 EGF-CFCs have also been found to interact with TGF-βs other than Nodal, 
resulting in the inhibition or promotion of Smad2/3 activity. Vg1, which is another 
member of the TGF-β superfamily and is Cripto-dependent, promotes mesoderm and axis 
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formation in Xenopus, while in mice it aids in the establishment of the primitive streak.62-
64 Mouse GDF1 and GDF3 are Vg1 homologs, which signal through the ALK4 and 
ActRIIB receptors, and similar to Nodal, both require Cripto to act as a co-receptor to 
activate Smad2/3.65,66 Another ligand in the superfamily, TGF-β1, has been shown to 
have anti-tumorigenesis effects.67 Studies done utilizing siRNA to deplete Cripto 
expression in cells, however, resulted in a loss in the anti-proliferative effects of TGF-β1 
as Cripto interferes with receptor-ligand assembly.68 By the same mechanism, Cripto also 
blocks activin-A and activin-B.69 Overall, Cripto plays a crucial role in both 
tumorigenesis and development as it acts as a co-receptor or antagonist to TGF-β1 
ligands. 
The importance of Cripto reaches beyond development as it has been found that 
its upregulation correlates with the progression of cancer cells such as breast carcinoma 
and melanoma.70,71 This underlines Cripto’s role in differentiation as while it helps in the 
proper maturation of germ layer cells during development, it also aids in the “regression” 
of differentiation of adult cells; thus giving it a key role in oncogenesis. 
CHAPTER 2: Results 
2.1 THE FOUR DOMAINS OF XENOPUS LEFTY PROTEIN  
 Preliminary work in the Branford lab on Xlefty was aimed at determining which 
part of the protein is necessary to antagonize Nodal signaling. To do so, they divided 
Xlefty into four regions - the PD (prodomain) and three mature domains (M1, M2, and 
M3) - to learn more about its antagonistic capability (Figure 2.1). Included in the 77 
amino acids (aa) PD is the signal sequence of Xlefty, which is presumably cleaved in the 
endoplasmic reticulum. Prodomain removal by SPC (Subtilisin-like Protein Convertase) 
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cleavage is a hallmark of many TGF-βs including Lefty, and it produces a mature, 
functional form. Once the PD is cleaved, the first part of the mature Xlefty according to 
our division is M1 (70 aa), which is characterized at its C-terminus by the second SPC 
cleavage site. It is believed that the second site is not utilized by the Xenopus embryo 
during gastrulation.28 The M2 domain consists of 110 aa followed by the 109 aa M3 
domain, which contains the highly-conserved cysteine knot that characterizes TGF-B 
proteins. Following their Nodal-Xlefty studies, I also utilized these domain divisions in 
my Xlefty-XCr1 investigations. 
 
Figure 2.1 Xlefty domains and truncations. The wild-type Xlefty was divided into four 
regions and two cleavage sites (arrowhead and arrow). Xlefty truncations were 
constructed by eliminating regions from the C-terminus, producing the HA-tagged 
proteins Xlefty∆M3, Xlefty∆M2/M3, and PD. Also, either the first, second, or both 
cleavage sites were altered in full length Xlefty so that they are no longer recognizable to 
SPCs. These cleavage site mutants were named site 1-myc, site 2-myc, or dbl mutant-
myc, respectively (constructs not depicted).  
 
The Branford lab first investigated the Xlefty∆M3 construct, which lacks the M3 
domain. Because the M3 region contains the cysteine knot, a hallmark of TGF-βs, we 
predicted that it might be responsible for blocking Nodal. To test this prediction, Xnr1 
(Xenopus Nodal-related 1) mRNA was injected in the “neutral” (ectodermal) animal cap 
with or without three increasing amounts of Xlefty∆M3 mRNA at the 16-cell stage. The 
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wild-type ectodermal layer does not express any Nodal ligands, thus it is referred to as 
“neutral” in terms of Nodal signaling. Goosecoid (gsc), a homeodomain transcription 
factor as well as a dorsal organizer gene, and Xenopus brachyury (Xbra), a T-box 
transcription factor and a pan-mesodermal gene, both rely on the Nodal signaling 
pathway for their transcription; thus, the group fixed the embryos and performed in situ 
hybridization to visualize the mRNA expression of these two genes. Their results showed 
that gsc and Xbra expression was ectopically induced in the Xnr1-injected animal cap and 
that the co-injection of full-length Xlefty was able to entirely suppress ectopic gsc 
expression, while Xbra expression was only reduced (Figure 2.2). In contrast, coinjection 
of Xnr1 and 1ng of Xlefty∆M3 led to suppression of both gsc and Xbra expression (Figure 
2.2), suggesting that M3 is not necessary for Nodal inhibition. They then examined the 
function of the other regions of Xlefty by co-injecting Xnr1 mRNA into the animal cap 
with 1ng of Xlefty∆M2/M3 or PD mRNA. They observed that embryos coinjected with 
Xlefty∆M2/M3 and Xnr1 mRNA had no expression of ectopic gsc and Xbra, while the PD 
had no effect on the induction of ectopic gsc and Xbra (Figure 2.2). Overall, their data 
suggested that M1 is the region necessary to inhibit Nodal signaling because the absence 
of M2 and M3 did not prevent Xlefty∆M2/M3 from blocking Nodal and the PD alone was 
unable to do so. Furthermore, the M2 and M3 regions seem to be inhibitory in the context 
of full-length Xlefty as it was not able to entirely suppress the ectopic expression of Xbra. 
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Figure 2.2 The M1 domain of Xlefty inhibits the expression of gsc and Xbra, both of 
which are Nodal-dependent. Xnr1 mRNA was injected by itself or co-injected with 
Xlefty, Xlefty∆M3, Xlefty∆M2/M3 or PD mRNA into the animal cap. Gsc and Xbra 
expression was then assayed by in situ hybridization to determine which region of Xlefty 
effectively blocks Nodal as the expression of both genes are dependent on Nodal 
signaling. Co-injection of Xnr1 with Xlefty, Xlefty∆M3, or Xlefty∆M2/M3 inhibited the 
ectopic gsc and Xbra expression, whereas PD did not. The common domain among the 
constructs that repressed gsc and Xbra is M1, suggesting that M1 is the region 
responsible for inhibiting Nodal. All panels depict the animal pole. 
 
 From the Xlefty truncation constructs, the lab showed that M1 is the functional 
region of Xlefty in blocking Nodal signaling. Cripto is indispensable to Nodal signaling 
and it has previously been shown that it interacts with Xlefty, but it is unknown as to 
which domains in Xlefty interact with Cripto.36,72 Ultimately, my aim is to determine 
whether the M1 region necessary for blocking Nodal signaling, as found in our 
unpublished results, is the same one that interacts with the obligate co-receptor Cripto. 
2.1.A XCR1 CO-IMMUNOCIPRITATES MATURE XLEFTY 
Lefty must be cleaved at site 1 to release the mature form that is able to inhibit 
Nodal signaling (Figure 2.1, Figure 2.2). I co-injected 1ng of XCr1-3 FLAG mRNA with 
400pg of Lefty-HA mRNA in the dorsal right cell of four-cell stage Xenopus embryos. 
Then at stage 12 of gastrulation, I collected embryos that were uninjected, co-injected, or 
injected with XCr1 or Lefty only. From the whole embryo lysates, I immunoprecipitated 
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XCr1 using anti-FLAG antibody and then detected with anti-HA antibody on a western 
blot. My results showed that XCr1-3 FLAG always co-immunoprecipitated the 40kD 
mature form of Lefty-HA but did not co-IP with the 49kD uncleaved Xlefty (Figure 2.3). 
These results correlate with the studies showing that only mature Xlefty blocks Nodal.28 
This is also strengthened by our site 1 cleavage mutant results, as will be discussed in a 
later section (Figure 2.8). 
          α-FLAG                         α-FLAG         α-FLAG     α-FLAG 
                    _______                            ___               ___             ___ 
                           L        1x       2x                   L        2x        L      2x      L       2x   
XCr1-3 FLAG     +         +        +                     +        +          -       -        -         - 
Lefty-HA             +         +        +                     -         -          -        -       +        + 
 
α-HA 
 
 
 
 
α-FLAG 
49kD 
 
 
40kD 
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Figure 2.3 XCr1 co-immunoprecipitates mature Lefty. The mature form of Xlefty, 
which undergoes cleavage at site 1, interacts with XCr1. 4-cell embryos were coinjected 
with XCr1-3FLAG, Lefty-HA, or XCr1-3FLAG and Lefty-HA mRNA and collected at 
stage 12. Embryonic extracts were immunoprecipitated with anti-FLAG antibody and 
detected on western blot with anti-myc or anti-FLAG antibodies. For co-IP control, 
XCr1-3FLAG was successfully detected at 26kD. L = lysate. 1x, 2x = 3.5µl, 7µl IP 
sample. 
 
2.1.B XCR1 DOES NOT INTERACT WITH THE PRODOMAIN OF XLEFTY 
 The prodomain is thought to regulate Lefty’s ability to block Nodal signaling as it 
needs to be cleaved to release the mature, functioning form.28 The PD is not known to 
directly antagonize Nodal based on our preliminary results (Figure 2.2), thus I 
hypothesized that it could not bind to the obligate co-receptor XCr1. I tested this 
possibility by co-injecting 1ng XCr1-3FLAG with 400pg PD-HA. At stage 12 of late 
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gastrulation, I collected the lysates of embryos that were uninjected, co-injected, or 
injected with Cripto or PD alone. I then performed western blotting with anti-HA 
antibody following immunoprecipitation with anti-FLAG antibody, and my results 
showed no interaction between XCr1 and the PD (Figure 2.4).  
                                      α-FLAG     α-FLAG         α-FLAG       α-FLAG 
                   ________                          ___                 ___              ___   
          L       1x       2x                 L         2x         L       2x      L        2x 
XCr1- 3 FLAG     +       +         +                   +         +           -        -        -          - 
PD- HA                +       +         +                    -          -           -        -        +         + 
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Figure 2.4 XCr1 does not interact with the prodomain of Lefty. The prodomain ran at 
9kD in the co-injection and PD-HA lysates. My results did not detect the prodomain in 
the co-IP, suggesting that PD and XCr1 do not interact. 4-cell embryos were coinjected 
with XCr1-3FLAG, PD-HA, or XCr1-3FLAG and PD-HA mRNA and collected at stage 
12. For co-IP control, Cripto-3FLAG was successfully detected at 26kD. Embryonic 
extracts were immunoprecipitated with anti-FLAG antibody and then probed with anti-
HA or anti-FLAG antibodies by western blotting. L = lysate. 1x, 2x = 3.5µl, 7µl IP 
sample.  
 
2.1.C XCR1 DOES NOT CO-IMMUNOPRECIPITATE XLEFTY∆M3 
TGF-βs contain a highly conserved cysteine knot in the C-terminus, which is in 
the M3 domain of Xlefty. Moreover, the cysteine knot has been shown to be important 
for dimerization.73 However, initial phenotypic findings by the Branford lab showed that 
in the ectodermal animal pole where Nodal signaling is not present Xlefty∆M3, when co-
expressed with Nodal, was able to suppress Nodal-dependent expression of the 
mesodermal markers gsc and Xbra (Figure 2.2). Because we observed that Xlefty is still 
able to block Nodal-dependent genes in the absence of M3, I hypothesized that the M3 
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region is not required for the interaction of Xlefty with Cripto. Using our Xlefty∆M3 
truncation, I investigated this possibility. To determine if Xlefty∆M3 binds XCr1, I 
collected embryos at stage 12 that were uninjected, co-injected with 1ng of XCr1-3FLAG 
and 400pg of Xlefty∆M3 mRNA, or injected with 1ng Cripto mRNA or 400pg Xlefty∆M3 
mRNA alone. Whole embryo lysates were co-immunoprecipitated using anti-FLAG 
antibody then probed with anti-HA antibody on a western blot. I did not detect interaction 
between this truncation and the co-receptor, which suggests that M3 is not necessary for 
XCr1 interaction (Figure 2.5). This result also concurs to our phenotypic observations on 
the suppression of Nodal-dependent genes by Xlefty∆M3 (Figure 2.2). 
                                        α-FLAG                    α-FLAG        α-FLAG       α-FLAG 
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Figure 2.5 XCr1 does not co-immunoprecipitate Xlefty∆M3. The cleaved (37kD) and 
uncleaved (46kD) forms of Xlefty∆M3 were successfully detected in the co-injection and 
Xlefty∆M3-only lysates. My results showed that this truncation does not interact with 
XCr1 to inhibit Nodal as we did not detect co-immunoprecipitation. For the co-IP 
control, Cripto-3FLAG was successfully detected at 26kD. The XCr1 doublet has 
previously been detected in the literature, with the glycosylated form running at 26kD 
and an unglycosylated form at 17kD.33 4-cell embryos were coinjected with XCr1-
3FLAG, Xlefty∆M3-HA, or XCr1-3FLAG and Xlefty∆M3-HA mRNA and collected at 
stage 12. Embryonic extracts were immunoprecipitated with anti-FLAG antibody and 
detected on western blot with anti-HA or anti-FLAG antibodies. L = lysate. 1x, 2x = 
3.5µl, 7µl of IP sample. 
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2.1.D XCR1 INTERACTS WITH XLEFTY∆M2/M3 
 Branford et al. showed that in the animal cap both Xlefty∆M3 and Xlefty∆M2/M3 
effectively block Nodal signaling (Figure 2.2). The common domains for these two 
truncations are M1 and the PD. They had previously shown that the overexpression of the 
prodomain does not affect the embryo during gastrulation (data not shown) and that the 
PD did not affect gsc and Xbra in animal caps (Figure 2.2). Moreover, they also showed 
that neither M2 nor M3 were necessary for Xlefty to block Nodal signaling (Figure 2.2). 
In support of their phenotypic results, my immunoprecipitation findings showed that PD 
does not interact with XCr1 (Figure 2.4), and that M3 is not necessary for XCr1-Xlefty 
either (Figure 2.5). I therefore hypothesized that M1 is the region that interacts with the 
obligate co-receptor. To determine if this is true, I immunoprecipitated XCr1-3 FLAG 
and then detected Xlefty∆M2/M3-HA by western blot. My results showed binding 
between XCr1 and Xlefty∆M2/M3 (Figure 2.6), which Branford et al. also found 
necessary for blocking Nodal signaling. In the absence of the prodomain, as in post-
cleavage Xlefty∆M2/M3, XCr1 is able to interact with M1, which runs at 17kD (Figure 
2.6). This gives strength to our earlier hypothesis that the PD is inhibitory to the mature 
form of Xlefty. Furthermore, the M2 region seems to have some inhibitory effect on 
interaction as there was a lack of interaction between XCr1 and Xlefty∆M3, even though 
M1 is present. In the context of Nodal signaling as a whole, the interaction between M1 
and XCr1 may be how Lefty prevents XCr1 from acting as an obligate co-receptor, which 
in turn inhibits Nodal signaling. To my knowledge, this result showing the binding of 
Cripto to this region of Xlefty is a novel finding.  
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Figure 2.6 The M1 domain interacts with XCr1. M1, post-prodomain cleavage, runs at 
17kD and was successfully detected in the lysates of the co-injection and the 
Xlefty∆M2/M3-only lysate lanes. Co-immunoprecipitation of Cripto with this domain 
suggests that M1 contains the co-receptor’s binding site in Xlefty. 4-cell embryos were 
coinjected with XCr1-3FLAG, Xlefty∆M2/M3-HA, or XCr1-3FLAG and Xlefty∆M2/M3-
HA mRNA and collected at stage 12. Embryonic extracts were immunoprecipitated with 
anti-FLAG antibody and detected on western blot with anti-HA or anti-FLAG antibodies. 
For co-IP control, Cripto-3FLAG was successfully detected at 26kD. L = lysate. 1x, 2x = 
3.5µl, 7µl IP sample. 
 
 Out of all the Xlefty truncation constructs, our results showed that only M1 co-
immunoprecipates Xlefty. Moreover, we detected the mature, cleaved Xlefty interacting 
with XCr1. Since XCr1 is an obligate co-receptor of Nodal, our results thus support 
previous studies stating that the cleaved form of Xlefty blocks Nodal signaling.33,72 From 
our biochemical and phenotypic observations, we predict that PD co-injected with Nodal 
would result to an expanded mesoderm due to unregulated Nodal signaling, while co-
injection of Xlefty∆M2/M3 or Xlefty∆M3 with Nodal would result to normal mesoderm 
due to the presence of M1 (Figure 2.7). Overall, we show that M1 is the region 
responsible for the inhibitory activity of Xlefty by binding XCr1, and the mature form of 
Xlefty is necessary to block Nodal signaling. 
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Nodal 
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+           ! Normal mesoderm                                          
+           ! Expanded mesoderm 
+           ! Normal mesoderm 
+          ! Normal mesoderm  
Figure 2.7 Nodal co-injection with Xlefty and its truncation constructs. Co-injection 
of Nodal with Xlefty or its truncations, except for PD, results in normal mesoderm 
development based on our phenotypic and co-immunoprecipitation findings. 
 
2.2 XLEFTY CLEAVAGE MUTANTS 
2.2.A UNCLEAVED XLEFTY DOES NOT CO-IMMUNOPRECIPITATE XCR1 
To examine the results that cleavage of the PD is required for Xlefty interaction 
with XCr1 (Figure 2.3), we mutated the first cleavage site (site 1-myc) so that it is no 
longer recognizable by SPCs. Consequently, the mature form is not produced from this 
construct because the PD cannot be released from the mature protein (Figure 2.8). XCr1 
cannot bind this mutant protein that is equivalent to uncleaved Xlefty (Figure 2.8). This 
gives further evidence that the mature, PD-less form of Xlefty interacts with XCr1 to 
block Nodal signaling (Figure 2.3). I do not, however, completely dismiss the possibility 
that the co-receptor binds to uncleaved Lefty because I was unable to consistently detect 
the proprotein form in our co-injection lysates. Overall, my results showed that Lefty 
interacts with Cripto in X. laevis. Furthermore, I showed that it is only the mature Lefty 
that co-immunoprecipitates Cripto, suggesting that the PD prevents interaction (Figure 
2.3 and Figure 2.8). Although the mature Xlefty-XCr1 interaction had been suggested 
previously, to my knowledge my co-immunoprecipitation results are the first to show 
direct evidence of it. 
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Figure 2.8 XCr1 does not interact with full-length Xlefty. No interaction was detected 
between the site 1-myc mutant construct and XCr1. This mutant construct cannot be 
recognized by SPCs due to mutations at site 1, and this construct is similar to the 
proprotein.  4-cell embryos were coinjected with XCr1-3FLAG, site 1-myc, or XCr1-
3FLAG and site 1-myc mRNA and collected at stage 12. Embryonic extracts were 
immunoprecipitated with anti-FLAG antibody and detected on western blot with anti-
myc or anti-FLAG antibodies. For co-IP control, XCr1-3FLAG was successfully detected 
at 26kD. L = lysate. 1x, 2x = 3.5µl, 7µl IP sample. X = mutated site. 
 
2.2.B XCR1 DOES NOT INTERACT WITH XLEFTY SITE 2 CLEAVAGE MUTANT 
  While cleavage at site 1 is indispensable to Xlefty activity, less is known about 
the significance of site 2.28 To determine if the Xlefty site 2 cleavage mutant interacts 
with the co-receptor, I co-injected the site 2 cleavage mutant mRNA with XCr1-3FLAG 
mRNA and collected the embryos at stage 12 along with the uninjected controls or those 
injected with site 2-myc or XCr1-3FLAG alone. I co-immunoprecipitated using anti-
FLAG antibody and probed with anti-myc antibody on a western blot. I detected the 
uncleaved Xlefty protein at 59kD as well as the mature form (50kD) as expected given 
that the first cleavage site was wild-type. But surprisingly, interaction with XCr1 was not 
detected (Fig 2.9). Although the site2-myc XLefty has a second-site mutation, it is 
otherwise similar to the wild-type as its mature form does not contain the PD and its first 
cleavage site is recognized by SPCs. The lack of binding to XCr1 thus suggested that this 
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site may be important to proper activity or processing of Lefty. In support of this, 
previous findings in the lab showed that the uncleaved form of Xlefty seems to be 
enriched compared to the mature when site 2 is mutated (data not shown). We also 
created a Xlefty mutant construct in which both cleavage sites are mutated to an 
uncleavable sequence (dbl-mutant-myc). Co-IP results with this double cleavage mutant 
showed lack of interaction with XCr1 (Figure 2.10). These site-2 Xlefty mutant results 
suggest that perhaps the second cleavage site plays a role in Xlefty’s interaction with 
XCr1 by affecting Xlefty’s folding or the post-translational protein modifications it 
undergoes.28 
                                     α-FLAG                      α-FLAG       α-FLAG       α-FLAG 
                   ________                        ___              ___              ___ 
          L       1x       2x                 L       2x       L       2x       L       2x 
XCr1-3 FLAG     +        +        +                   +        +        -         -         -         -         
Site 2- myc         +        +        +                   -         -         -         -        +        + 
  
59kD 
 
50kD 
 
 
26kD 
 
α-myc 
 
 
 
α-FLAG 
 X 
* * * * 
*            * * * 
Site 2- myc 
 
Figure 2.9 XCr1 does not co-immunoprecipitate the mature form of Xlefty when the 
second cleavage site of Xlefty is mutated. No co-immunoprecipitation of the cleaved 
site 2-myc by XCr1-3FLAG was detected in the co-injection lanes. 4-cell embryos were 
injected with XCr1-3FLAG, site 1-myc, or XCr1-3FLAG and site 1-myc mRNA and 
collected at stage 12. Embryonic extracts were immunoprecipitated with anti-FLAG 
antibody and detected on western blot with anti-myc or anti-FLAG antibodies. For co-IP 
control, Cripto-3FLAG was successfully detected at 26kD. L = lysate. 1x, 2x = 3.5µl, 7µl 
IP sample. X = mutated site. * = non-specific band. 
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                                        α-FLAG                            α-FLAG         α-FLAG        α-FLAG 
                        _________                            ___                 ___                ___ 
              L        1x         2x                 L          2x         L        2x        L        2x 
XCr1-3 FLAG          +         +          +                  +           +          -          -          -         - 
Dbl mutant- myc    +         +          +                   -            -          -          -          +        + 
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α-FLAG 
X 
 
X  
Dbl mutant- myc 
 
Figure 2.10 XCr1 does not bind Lefty when both cleavage sites 1 and 2 are mutated. 
The uncleaved Xlefty band was clearly detected at 59kD in the co-injection and double 
mutant lysate lanes. The bands in the co-IP lanes of co-injection are non-specific as I also 
faintly saw this band in the immunoprecipitation lane of those embryos injected with only 
XCr1-3FLAG. 4-cell embryos were coinjected with XCr1-3FLAG, site 1-myc, or XCr1-
3FLAG and site 1-myc mRNA and collected at stage 12. Embryonic extracts were 
immunoprecipitated with anti-FLAG antibody and detected on western blot with anti-
myc or anti-FLAG antibodies. For co-IP control, Cripto-3FLAG was successfully 
detected at 26kD. L = lysate. 1x, 2x = 3.5µl, 7µl IP sample. X = mutated site.  
 
Our results demonstrated the importance of site 1 cleavage to Xlefty’s inhibitory 
activity (Figure 2.3 and Figure 2.8). Cleavage at site 1 produces the mature form of 
Xlefty that is able to block Nodal signaling as well as bind XCr1 (Figure 2.2 and Figure 
2.3). In such case, normal mesoderm development occurs. In contrast, mutating site 1 
leads to unregulated Nodal signaling, which results to mesoderm expansion (Figure 2.11). 
We predict the same observation in a co-injection of double mutant construct with Nodal 
(Figure 2.11). Mutations at cleavage site 2 still allows Xlefty to block Nodal signaling via 
a non XCr1-dependent manner, as our phenotypic results showed (Figure 2.2). However, 
site 2 mutant is not longer able to co-IP XCr1 (Figure 2.9). Overall, cleavage at site 1 is 
necessary to block Nodal signaling in a XCr1 and non XCr1-dependent manner, and that 
site 2 seems to have a key role in Xlefty’s ability to bind the co-receptor. 
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Nodal Site 1- myc 
X 
+           ! Mesoderm expansion  
 X 
Site 2- myc Nodal +           ! Normal mesoderm 
X 
 
X  
Dbl mutant- myc Nodal +          ! Mesoderm expansion   
Figure 2.11 Nodal co-injection with Xlefty site mutants and its effect on mesoderm 
development. Mesoderm expansion results from co-injecting Nodal with constructs that 
have a mutation at cleavage site 1. 
 
2.3 EXCESS CRIPTO LEADS TO EMBRYOS WITH DORSAL OPENING, 
REMINISCENT OF XLEFTY∆M2/M3 OVEREXPRESSION  
 
Phenotypically, preliminary Xlefty∆M3 observations by our lab suggested that 
this truncation has a context-dependent activity. Injection of anti Xlefty morpholino, 
which binds Xlefty mRNA and prevents its translation, causes exogastrulation in 
embryos. This phenotype is attributed to expanded Nodal expression. When injected in 
the marginal cells of a 4-cell embryo, Xlefty∆M3 mRNA also caused exogastrulation and 
an expansion of gsc and Xbra expression, indicating inhibition of Xlefty function (data 
not shown). This contrasts with results from the animal cap injections as Xlefty∆M3 
injected in that region blocked Nodal activity (Figure 2.2). This finding piqued our 
interest on whether Xlefty∆M2/M3 also exhibits a context-dependent activity in the 
Nodal signaling pathway.  
 To test if the effect of Xlefty∆M2/M3 is also context-dependent, I injected the 
mRNA encoding this truncation was injected into all marginal cells of a 4-cell stage 
embryo. At the end of neurulation, 93% (n = 152/163) of the injected embryos had failed 
to undergo complete blastopore closure during gastrulation, resulting in severe openings 
in the body wall of the embryos (Figure 2.12 A, B, F, G). We further investigated by 
probing for gsc and Xbra expression at early gastrulation (st.10.5), and while gsc 
expression was similar to wild-type, Xbra was disrupted in a variety of ways from ring 
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reduction to expansion (Figure 2.12 C-E, H-J). This suggested that on one hand, 
Xlefty∆M2/M3 antagonizes Nodal and reduces Nodal-dependent Xbra expression (Figure 
2.2), and on the other hand, Xlefty∆M2/M3 can also help promote Xbra expansion 
perhaps by antagonizing Nodal’s inhibitor, Xlefty (Figure 2.9). Overall, our results 
suggest that Xlefty∆M2/M3 might stochastically antagonize Xlefty and Nodal activity. 
 
Figure 2.12 Xlefty∆M2/M3 overexpression disrupts blastopore closure and 
mesodermal differentiation. (A, F) The blastopore of a wild-type embryo is nearly 
closed at the final stage of gastrulation (A), while Xlefty∆M2/M3-overexpressing 
embryos failed to complete the process (F). (B, G) The effect of this failure of blastopore 
closure is even more apparent at stage 20, when embryo elongation is actively occurring. 
(C–J) To examine these embryos at the molecular level, we assayed the Nodal-dependent 
expression of gsc and Xbra by in situ hybridization. Gsc is unperturbed at st.10.5 (C, H). 
However, Xbra was disrupted (D, E, I, J). (A, C-F, H-J) Vegetal view. Arrowheads mark 
the dorsal lip. (B, G) Dorsal view. Anterior to left. 
 
 While performing the Xlefty-Xcr1 co-IPs, I observed an interesting phenotype in 
the XCr1-injected embryos. Sixty-six percent of the embryos (n=76) injected with 1ng of 
Cripto in the dorsal right cell during the 4-cell stage had delayed blastopore closure 
during late gastrulation (stage 12). At stage 24, 54.6% of these embryos (n=75) failed to 
entirely close their blastopore, resulting in a dorsal opening where the yolk is exposed 
(Figure 2.13 B, D, F, H). To my knowledge this severe “open-back” phenotype is a novel 
finding for XCr1. We also observed the finger-like projections that were previously 
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reported in the literature (Figure 2.13 C, G) though the predominant phenotype was the 
dorsal opening.  
A 
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Figure 2.13 Overexpression of XCr1 causes "open-back," a novel phenotype. Over-
expression of the Nodal obligate co-receptor, XCr1, resulted in embryos with a dorsal 
opening. 1ng of XCr1-3FLAG was injected in the dorsal right of a 4-cell embryo and 
these embryos were analyzed at stage 24 (A-D) and stage 40 (E-H). (A, E) Uninjected 
embryos. (B-D, F-H) XCr1 overexpression led to dorsal opening (B, D, F, H), disruptions 
in eye development (D, F, H), finger-like projections (C, G), and ectopic cement glands 
(F, H). (A-D) Lateral view, anterior to the left. (E-H) Lateral view, anterior to the right. 
ß = eye, ß = finger-like projection, ß = ectopic cement gland. 
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 To determine the cause of this “open-back” phenotype, I examined the expression 
patterns of various genes by in situ hybridization (Figure 2.14). Gsc, a homeodomain 
transcription factor that marks the dorsal organizer, chd, a dorsalizing factor and BMP 
antagonist that also marks the dorsal organizer and later marks the notochord, and Xbra, a 
T-box transcription factor that also marks the organizer and notochord, as well as the 
prospective mesoderm in early gastrulation, were chosen as their transcription depends on 
Nodal signaling during development. In early development, the organizer serves as an 
important signaling center that patterns the embryo axes and directs germ layer 
specification. I also decided to use edd (endodermin) as a marker of endoderm cells. 
Incomplete dorsal closure often indicates disruption of the dorsal mesoderm and 
potentially a shift to ventral mesoderm specification. For this reason, I used the secreted 
growth factor and developmental regulator, wnt8, to visualize the ventral mesoderm in 
the mutant embryos.  
XCr1 mRNA was microinjected into the dorsal right cell of embryos at the 4-cell 
stage, and then the embryos were fixed either at early gastrulation or neurulation for in 
situ hybridization. At stage 10.25, the organizer genes gsc and chd are unaffected at the 
onset of development when XCr1 is in excess (Figure 2.14 A, B, E, F). Wnt8 and edd 
were also probed to detect changes in ventral mesoderm and endoderm, respectively. 
Neither was affected by the overexpression of XCr1 (Figure 2.14 C, D, G, H). Thus, 
XCr1-overexpressing embryos exhibited normal endoderm development, and the open-
back phenotype is not due to the dorsal mesoderm differentiating as ventral mesoderm. 
Further, because our results showed that the expression of gsc and chd were not perturbed 
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in XCr1-overexpressing embryos, the disruption of the dorsal mesoderm is not due to 
perturbation of the organizer. 
 
A B C D 
E F G H 
 
 
Uninjected 
 
 
 
 
 
 
 
 
Injected 
             gsc                          chd                         wnt8               endodermin                      
 
 
Figure 2.14 Gsc, chd, wnt8, and endodermin expression are unchanged at the onset of 
gastrulation by the overexpression of XCr1. Embryos were fixed at stage 10.25 (A, B, 
E, F) or stage 10.5 (C, D, G, H) and assayed for various genes using in situ hybridization. 
(A, B, E, F) Overexpression of XCr1 did not affect the expression of the organizer 
markers goosecoid (A, E) and chordin (B, F). (C, D, G, H) Endodermin and wnt8 and are 
expressed in the endoderm and ventral mesoderm, respectively. Both were unaffected by 
XCr1 overexpression. (A-D) Uninjected. (E-H) XCr1-overexpressing embryos (A-H). 
Vegetal view, dorsal to top.  
 
Nodal signaling has been shown to induce Xenopus brachyury (Xbra) expression 
during gastrulation.74 Xbra is expressed by presumptive mesodermal cells and can be 
found adjacent to the blastopore at stage 10.5, circling the structure. To determine if the 
open-back phenotype seen in embryos overexpressing XCr1 is due to disrupted 
mesoderm formation, we probed for Xbra at stage 10.5 by in situ hybridization.  I 
observed that the typical ring-like expression above the blastopore lip seen in uninjected 
embryos was either discontinuous or reduced in the XCr1-overexpressing embryos, and 
the disruption consistently appeared in the same location, namely the dorsal lip region. 
Typically, perturbation of Xbra at the dorsal lip affects the development of dorsal 
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mesoderm. We also saw similar phenotypic results in embryos overexpressing 
Xlefty∆M2/M3 with anomalous Xbra expression leading to an open-back phenotype 
(Figure 2.12). My XCr1 findings, however, more consistently showed a dorsal disruption 
of Xbra expression (Figure 2.15), while perturbation by Xlefty∆M2/M3 varied from 
expansion or depletion of Xbra expression around various regions of the blastopore 
(Figure 2.12 D, E, I, J).  
 The notochord, which forms during gastrulation and neurulation, is derived from 
dorsal mesoderm and convergent extension helps in “zipping” notochord cells into a thin, 
antero-posteriorly elongated structure. Given that the dorsal mesoderm was disrupted 
(Figure 2.15), we hypothesized that notochord formation might be perturbed in XCr1-
overexpressing embryos. Xbra and chd both mark the notochord as it develops during 
neurulation; therefore, I examined the expression pattern of these genes by in situ 
hybridization. A thick, shortened notochord was observed in the XCr1-overexpressing 
embryos in contrast to the slender, elongated notochord in the uninjected (Figure 2.16). 
These results suggest a perturbation and delay in convergence extension. Moreover, the 
aberrant notochord formation correlates with the disruption of dorsal Xbra expression we 
observed in the earlier stages of development as the notochord is derived from dorsal 
mesoderm (Figure 2.16 B, C). Overall, my results showed that overexpressing XCr1 in 
embryos disrupts Nodal-dependent dorsal mesoderm, as shown by the Xbra expression 
pattern in early gastrulation (Figure 2.12), and consequently the lack of dorsal midline 
closure by convergent extension. To my knowledge, this effect of XCr1 overexpression is 
a novel observation. 
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Figure 2.15 Xbra expression pattern suggests dorsal mesoderm perturbation in 
XCr1-overexpressing embryos. Control embryos and those overexpressing XCr1 were 
collected at stage 10.5 of gastrulation and stained for Xbra expression. (A) Control 
embryos showed a strong, evenly distributed, continuous ring around the blastopore. In 
contrast, mutant embryos lacked even distribution of Xbra (B, C), and in some cases, 
Xbra expression was partially ablated (C). The disruption in Xbra staining often occurred 
around the blastopore lip (B, C) suggesting perturbation to the prospective dorsal 
mesoderm. (A-C) Vegetal view, dorsal to top. Arrowhead = blastopore lip. 
 
 
A 
 
B C 
D E F 
    Uninjected                                          Injected 
Chd 
 
 
 
 
 
 
 
 
Xbra 
!                                           !                                     !                                                                  
!                                            !                            "     
 
Figure 2.16 Aberrant Xbra and chordin pattern during neurulation suggest 
perturbed convergent extension. (A, D) Both Xbra and chordin control embryos 
showed a slender, elongated staining of the notochord. (B, C, E, F) In contrast, a variation 
in staining pattern was observed in mutant embryos. (B) For chordin, a short and 
thickened notochord staining was observed when XCr1 was overexpressed. (C) In some 
embryos, the notochord is relatively more elongated, though it is still slightly dispersed 
and is misaligned with the blastopore. (E, F) XCr1-overexpressing embryos stained with 
chd also showed perturbed notochord formation, with very little notochord detected (A-
A B C 
^ ^ ^ 
 
  
35 
F). Dorsal view, posterior at top. Arrow = blastopore. Embryos were collected at stage 13 
of early neurulation to examine notochord formation using the probes chordin (A-C) and 
gsc (D-F). 
 
CHAPTER 3: Discussion 
 
 The importance of the Nodal signaling pathway during development is 
underscored by the embryonic lethality or phenotypic mutations observed upon its 
disruption.75 In zebrafish, for example, Nodal signaling is prevented in the absence of the 
Cripto homologue Oep, leading to one-eyed embryos.36 Furthermore, unregulated Nodal 
signaling in the case of Lefty absence leads to exogastrulation in Xenopus.76 To date, 
studies have shown two ways in which Xlefty prevents Nodal signaling: 1) through 
binding with Nodal and 2) through interacting with Cripto and preventing it from binding 
Nodal. In our studies, we divided Xlefty into domains based on distinct characteristics 
such as sequence conservation or cleavage sites to pinpoint the role of these Xlefty 
domains in Nodal inhibition (Figure 2.1). I also pursued phenotypic and molecular 
studies on Cripto to further understand its role in germ layer specification and cell 
movement early in gastrulation. 
Preliminary phenotypic findings by our lab regarding the Xlefty domains 
suggested that the M1 region was responsible for the ability of Xlefty to antagonize 
Nodal signaling (Figure 2.2). Xlefty interacts with Nodal and Nodal’s obligate co-
receptor, Cripto, to regulate proper amount of mesendoderm in an embryo. Our 
experiments showed that mature Xlefty, Xlefty∆M3, and Xlefty∆M2/M3 were all able to 
successfully block Nodal-dependent ectopic induction of the mesodermal markers gsc 
and Xbra in the animal pole (Figure 2.2). The commonality in these constructs was the 
M1 domain, thus suggesting that it is responsible for binding Nodal and/or Cripto and 
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inhibiting Nodal signaling. The M3 region was not necessary for antagonism, and this 
finding is interesting as the M3 region contains the cysteine-rich region that is a defining 
characteristic of TGF-βs due to its conservation. However, it might not be surprising that 
Xlefty does not require M3 as it is an atypical member of the superfamily. If other 
Cripto-dependent TGF-Bs share an “M1-like” domain, it would be interesting to see if 
there is some conservation of activity or molecular structure within this region. We know 
that Lefty binds Cripto, Nodal requires Cripto, and that M1 is the Nodal-inhibiting 
domain, so then we asked if the M1 domain interacts with Cripto.45,77  
 Cripto is necessary for Nodal signaling. Gritsman et al showed that Nodal 
signaling in zebrafish was unable to proceed in the absence of oep, demonstrating that the 
EGF-CFC co-receptor is indispensable to this pathway.36 One of the mechanisms that 
Lefty utilizes to prevent Nodal signaling is by interaction with Cripto.38 Thus we 
performed co-IP experiments with XCr1 and Xlefty and its various truncations. Our co-IP 
results showed interaction between the mature form of Xlefty and XCr1 (Figure 2.3).  To 
my knowledge, this interaction has not been shown before in Xenopus. Moreover, my 
findings highlight the importance of cleavage to the function of Xlefty. That is, the 
prodomain must be removed by SPCs for Xlefty to inhibit Nodal signaling via interaction 
with XCr1. Further investigation revealed that of all the Xlefty truncations – PD alone, 
Xlefty∆M3, and Xlefty∆M2/M3 - only Xlefty∆M2/M3 co-immunoprecipitated Cripto 
(Figures 2.4-2.6). Thus, not only is M1 sufficient for blocking Nodal signaling, it is the 
same domain which co-immunoprecipitated XCr1 (Figure 2.6). The next step is to 
determine if this interaction between Xlefty and Cripto is direct and if the same holds true 
for Nodal and Xlefty interaction. Further studies could be done to determine which amino 
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acids are responsible for making M1 the inhibitory domain and if they are the same ones 
that bind XCr1. From a clinical angle, a therapeutic drug that resembles the M1 domain 
of Xlefty could be key in regulating enhanced Cripto and Nodal activity in various types 
of cancer. 
 Previous studies on Xlefty have shown that post-translational cleavage to release 
its mature form is crucial to its inhibitory activity.  My results showing that the cleaved 
mature Xlefty, but not uncleaved Xlefty, interacts with Cripto concur with these findings 
(Figure 2.3 and Figure 2.8). Critical to this protein processing is the recognition of the 
first cleavage site by SPCs to release the prodomain from the mature form of Xlefty. 
Indeed, our western blots did not detect interaction between uncleavable site 1 mutant 
Xlefty and XCr1 (Figure 2.8). The fact that the cleaved mature form of Xlefty interacts 
with XCr1 and this interaction was lost when cleavage is absent suggests that the 
prodomain is inhibitory and its cleavage from Xlefty is crucial for Nodal signaling 
inhibition (Figure 2.3 and Figure 2.8). 
 Another interesting observation involved the Xlefty site 2 cleavage mutant. It has 
been established that mature Xlefty is the functional form of the protein capable of 
inhibiting Nodal signaling.28 SPCs cleave the Xlefty proprotein at site 1 between the 
prodomain and the M1 domain of Xlefty, consequently releasing the mature form.28 
While cleavage at site 1 is critical to the activity of the Xlefty, previous studies suggested 
that cleavage site 2 is not utilized during development in frogs.28 To my knowledge, site 
2 was only shown to be cleaved when Xlefty was artificially expressed in Xenopus 
oocytes, but such cleavage was not detected in Xenopus embryos.28 Thus, I hypothesized 
that mutating site 2 would still allow for XCr1 co-immunoprecipitation since site 1 is still 
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recognizable and a mature protein can still be produced. Suprisingly, XCr1 was unable to 
co-IP the cleavage site 2 mutant although the mature form of the protein was detectable 
in the lysate (Figure 2.9). Perhaps the integrity of site 2 is crucial to proper folding or 
processing of Xlefty, and even if mature protein is produced, it is not quite in the 
conformation it needs to function normally. Further support of this notion was seen in 
previous lab results wherein the mature form was detected on a western blot at a much 
lower level than the uncleaved form, suggesting an issue in proprotein processing. An 
interesting thought is that although the site 2 mutant has lost its ability to bind Cripto, it is 
still somehow able to effectively block Nodal signaling.40 Possibly, this construct can still 
bind Nodal as our preliminary results showed that it acts normally when overexpressed in 
embryos. Overall, my results suggest that perhaps site 2 is more important to Xlefty 
function than previously thought. In particular the fact that site 2 does not co-IP Cripto 
but can still block Nodal suggest that this construct might interact with Nodal. Perhaps 
the site 2 sequence is necessary for binding XCr1 either by direct interaction or by 
providing proper conformation of Xlefty.  
 Besides regulating the formation of the mesendodermal layer during gastrulation, 
TGF-βs are also known to promote proper cellular movement.78 Overexpression of XCr1 
resulted in a lack of blastopore closure during late gastrulation, which resulted in an 
“open back” at the tadpole stage (Figure 2.13 B, D, F, H). This phenotype is often caused 
by the disruption of mesoderm formation and convergent extension during gastrulation. 
Dorsal mesoderm and its subsequent convergent extension are necessary for notochord 
formation. Given that blastopore closure relies on the presence of mesoderm and 
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subsequently notochord formation by convergent extension, we examined these two 
events by in situ hybridization of XCr1-overexpressing embryos.  
At stage 10.5 of early gastrulation, I observed that there is often a breakage or 
depletion of mesoderm-specific Xbra staining at the blastopore lip in XCr1-
overexpressing embryos, which might lead to disruption or absence of dorsal mesoderm 
during later stages of development (Figure 2.15). Given that Nodal signaling is 
responsible for mesendodermal production, one might predict that overexpressing XCr1 
would enrich Nodal’s activity, leading to increased mesoderm. My results opposed this 
prediction as I observed depletion in Nodal-dependent Xbra expression, which suggests a 
disruption in dorsal mesoderm. One explanation for the counterintuitive results is that 
XCr1 could have a “sequestering” effect on Nodal. That is, excess XCr1 might bind the 
majority of Nodal, but the complex is not necessarily next to the type I/type II receptors 
at the cell surface for signaling. In other words, the concentration of the receptors is 
limiting. Nearly all Cripto phenotypic studies have been loss-of-function studies, but my 
experiments were somewhat unique as they studied the effect of XCr1 overexpression. 
Because one of my hypotheses is that XCr1 “sequesters” Nodal, it would be interesting to 
determine if overexpressing Nodal or its receptors would rescue the open-back phenotype 
caused by XCr1.  
 Dorsal mesoderm differentiates into notochord during the neurula stage.79 Dorsal 
closure relies on the presence of dorsal mesoderm, which forms the notochord and 
exhibits the movements of convergent extension. Xbra and chordin expression mark the 
notochord during early neurulation at stage 13. In wild type embryos, slender, elongated 
expression of Xbra and chordin genes runs anteroposteriorly and marks the developing 
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notochord (Figure 2.16 A, D). In contrast, expression patterns of these genes were 
weaker, shorter, thicker, or misaligned to a slightly open blastopore in XCr1-
overexpressing embryos, all of which suggest disrupted notochord development (Figure 
2.16 B, C, E, F). Thus, my results suggest that overexpressing Cripto perturbs convergent 
extension and to my knowledge this is a novel finding. 
 The literature suggests that convergent extension depends on the proper 
occurrence of mediolateral intercalation behavior (MIB), which takes place near the 
dorsal lip of the embryo.80 This model proposes that for convergent extension to proceed 
normally during gastrulation, cells need to interact by pulling on each other and creating 
a hoop of tension within the blastopore to promote mesoderm involution. Not only does 
this cellular movement require uniform tension, but also a “continuous supply” of its 
working material – the mesoderm. I hypothesize that MIB was critically disrupted upon 
overexpression of XCr1 and Xlefty∆M2/M3 due to incomplete cell specification. I 
consistently saw disruption of Xbra expression at the dorsal lip, which previous studies 
have shown can lead to dorsal opening.81,82 In support, my embryos showed disruption in 
Xbra expression near the dorsal lip, which is the region of MIB initiation, and developed 
into tadpoles that have an open back phenotype. Possibly in these embryos the disruption 
in mesoderm produces an uneven hoop of tension, disallowing cells from entirely 
involuting and subsequently perturbing gastrulation and dorsal closure. Notochord 
formation not only relies on the presence of mesodermal cells at a correct amount, but 
also on their proper involution for convergent extension; thus, my mutant embryos had a 
poorly formed notochord.83,84 My results therefore suggest that notochord development 
partly depends on tight control of XCr1 levels in developing embryos.  
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3.1 CONCLUSIONS AND FUTURE DIRECTIONS 
  Preliminary findings by our lab suggested that M1, not M3, is required for Nodal 
antagonism (Figure 2.5 and Figure 2.6). Here we give direct evidence that the mature 
form of Xlefty binds Cripto and that M1 is the same domain that interacts with the co-
receptor. While it is not thought that the second cleavage site of Xlefty is utilized during 
embryogenesis, my results suggest that the integrity of the RFHR site could be important 
to XCr1 interaction, perhaps by ensuring proper folding and/or post-translational 
processing of Xlefty. I also found that Cripto overexpression causes a novel phenotype 
wherein there is a failure of dorsal closure. I suggest that these XCr1-overexpressing 
embryos had aberrant mesodermal specification near the blastopore lip, which disrupts 
mediolateral intercalation behavior and ultimately convergent extension. 
 Future experiments would be geared toward answering a number of questions 
from our experimental findings via biochemical and phenotypic methods. I suggested that 
the integrity of the second cleavage site in Xlefty is necessary for the interaction with 
XCr1. The next step is to determine which amino acids are crucial to XCr1-Xlefty 
interaction or if the RFHR sequence as a whole needs to be intact. In other words, by 
making individual amino acid changes that are either similar in biochemical properties to 
the ones present in the wild-type or ones that are entirely different, I can determine if 
there is a degree in the loss of interaction between the two proteins. 
 I focused on mesoderm specification and convergence extension in our embryos 
exhibiting an “open-back” phenotype, and a more thorough study of these embryos needs 
to be done using other gene markers. For example, although I did not observe a change in 
endodermin gene expression at stage 10.25, I do not dismiss that it is not perturbed at 
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other stages because Nodal signaling is crucial to both mesoderm and endoderm 
formation. Because I am interested in notochord formation, the expression pattern of xnot 
may also be a good gene candidate to use for this structure. The presence of an ectopic 
cement gland and eye malformations in XCr1-overexpressing embryos also calls for in 
situ hybridization of gene markers specific for these anterior structures. Lastly, 
ectodermal markers could show if there is an overall disruption to ectoderm layer 
specification due to the drastic perturbation of the mesodermal layer. 
 While I found that overexpression of XCr1 results in dorsal opening in whole 
embryos due to the perturbation of convergent extension, my next experimental step 
would be to directly test this hypothesis using animal cap assays. Moreover, I need to 
further explore my “sequestration” hypothesis by co-injecting XCr1 with nodal to 
perform rescue experiments. Alternatively, I could also co-inject XCr1 MO with XCr1. If 
the sequestration hypothesis is correct, adding more Nodal should rescue the effects of 
XCr1 overexpression as there would be more Nodal to access the receptors. XCr1 MO 
should also be able to able to dampen the effects of XCr1 overexpression, which would 
prevent Nodal sequestration and should result to a rescued Nodal signaling. 
 While the Nodal signaling pathway is essential in germ layer cell differentiation, 
the same pathway aids in the de-differentiation of adult cells during oncogenesis. Various 
cancer studies have shown an upregulation of Cripto in cells that have become 
undifferentiated. While the specifics of Cripto activity in cancer may be different from 
how it functions during gastrulation, some similarities are likely. In the context of Nodal 
signaling, I believe that the M1 region of Lefty binds Cripto to prevent it from acting as 
an obligate co-receptor thereby blocking Nodal activity, which is essential to 
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mesendodermal cell differentiation. Thus, the M1 region of Lefty may have therapeutic 
utility in cancer treatment if it is also able to block Cripto and Nodal’s capability to 
promote de-differentiation of cells.  
Chapter 4: Materials and Methods 
 
4.1 Generation of XCr1-3FLAG construct 
 By PCR using Pfu (Thermo Scientific) we constructed a tagged Cripto containing 
three consecutive FLAGs at the C-terminus. The primers were ordered from Sigma with 
the following sequence for the forward primer: 5' CCA TCG ATG GAC CAT GCA GTT 
TTT AAG ATT TCT TGC C 3' and for the reverse primer: 5' GCT CTA GAC TAT TTA 
TCA TCA TCA TCT TTA TAA TCT TTA TCA TCA TCA TCT TTA TAA TCT TTA 
TCA TCA TCA TCT TTA TAA TCG AGT CCA ATA TTC AGA TGC  3'. PCR 
products and the vector were then digested overnight with ClaI and XbaI, and the vector 
pCS2+ was treated with Shrimp Alkaline Phosphatase (Promega) for two hours. Multiple 
rounds of purification of the PCR product using gel electrophoresis followed (Qiaquick), 
and Cripto-3 FLAG was then ligated overnight into pCS2+ using T4 DNA ligase. XL1-
Blue Supercompetent Cells (Stratagene) were then transformed with the ligation 
products. After alkaline lysis, DNA digests using the following enzymes were done to 
check if we indeed had XCr1-3 FLAG and if it was in the correct orientation: NotI for 
linearization, BamHI for gene orientation, and HindIII + NotI to cut XCr1-3 out of 
pCS2+. A midiprep was done on positive products and they were  sent for sequencing. 
4.2 RNA Transcription 
 To minimize RNA degradation, gloves and non-kit equipment were treated with 
RNase ZAP (Ambion). In preparation for microinjection, we took our linearized 
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pCS2+XCr1-3 FLAG, Lefty-HA, Lefty-myc, double cleavage mutant-myc, site1-myc, 
site 2-myc, Xlefty∆M2/M3-HA, and Xlefty∆M3-HA vector DNA and transcribed these 
samples using the mMESSAGE mMACHINE (Ambion) protocol. The products were 
purified using the MEGAclear Kit (Ambion) and quantified using a spectrophotometer. 
Our stock solutions were aliquoted and stored at -80ºC. 
 In preparation for in situ hybridization, transcription was performed on linearized 
DNA template using SP6 polymerase (Roche DIG RNA Labeling Kit) to produce 
antisense probes. The products were then purified (Bio Rad Micro Bio-Spin Columns 
with Bio-Gel P-30) and quantified against a RNA ladder (Fisher). Stocks were stored at   
-20ºC. 
4.4 RNA Microinjection  
 In vitro fertilization was done using eggs obtained from frogs treated with PMSG 
(Calbiochem) and HCG (Sigma) and testis preserved in fetal bovine serum (FBS). After 
fertilization and recovery, embryos were de-jellied with 4.5% L-cysteine and washed 
with 1/3 MMR. They were then submerged in a Ficoll-filled Petri dish and sat on a 15ºC 
cold plate throughout the microinjection. Custom-made needles were used to inject RNA 
samples into the dorsal-right cell once embryos reached the 4-cell stage. XCr1-3FLAG 
was injected in the amount of 1ng and 400pg for Xlefty cleavage mutants and 
truncations. Finally, embryos were transferred to ⅓MMR + Gentamycin to grow to the 
desired developmental stage. 
4.5 Co-immunoprecipitation 
 Fifteen embryos that received co-injection or single-injection were collected at 
gastrulation and lysed in 500µl 1X immunoprecipitation buffer (200µl 5X IP Buffer, 
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100µl Protease inhibitor (complete mini EDTA-free from Roche) solution, 50µl 10% 
Triton X-100, 650µl H2O). The 5X IP buffer contained 1M Tris-HCl pH7.5, 5M NaCl, 
0.5M EDTA, 0.5M NaF, 106mM Na4P2O7, and 01.M Na3VO4. The sample was spun for 
fifteen minutes at 4ºC to separate the aqueous layer. After careful pipetting, 200µl of the 
supernatant was incubated for two hours with mouse anti-FLAG at the concentration of 
1:200. Protein G agarose beads were then included in the mix and nutated for one hour. 
We again spun down the sample, took the supernatant, and washed the Protein G-
antibody-protein complex three times with 500µl lysis buffer. At the end of each wash, 
the buffer was removed with minimal disturbance to the beads. Finally, we stored the 
sample in lysis buffer and 1X Lamelli Buffer at 4ºC (3X Lamelli: 0.682g Tris base, 
0.666g Tris HCl, 4ml 20%SDS, 32.2µl 0.5M EDTA, 4ml glycerol, 2ml beta-
mercaptoEtOH, 1ml 0.1% bromophenol blue). 
4.6 Western Blot 
 10% separating (3.75ml 1M Tris HCl pH8.8, 3.33ml 37.5:1 
acrylamide/bisacrylamide, 50µl 20%SDS, 2.81ml H2O) and 4% stacking (1.25ml 0.5M 
Tris HCl pH6.8, 0.67ml 37.5:1 acrylamide/bisacrylamide, 25µl 20%SDS, 3.025ml H2O) 
gels were made according to the lab protocol. Co-immunoprecipitation samples and the 
protein ladder were heated in 70ºC H2O bath for 20 minutes, and the samples were 
vortexed previous to loading. Gels were run until a nice separation of ladder bands was 
achieved. In preparation for transfer, blotting pads were soaked in 1X transfer buffer. 
PVDF membrane was pre-wet in methanol for 30 seconds, rinsed in H2O for 5 minutes, 
and then further washed in 1X transfer buffer for 10 minutes. Proteins were then 
transferred on the membrane overnight before detection. We washed the membranes with 
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TBS the next day, dried it completely and then briefly submerged it in methanol for re-
activation. Alcohol was removed by washing the membrane three times in deionized H2O 
and three times in TBS-T before blocking in 5% milk + TBS-T for 1 hour. To detect co-
immunoprecipitation, we incubated with rabbit anti-FLAG, -HA, or -myc in 1:1,000 
concentration for one hour, then washed three times with TBS-T, five minutes each. We 
incubated our secondary antibody, goat anti-rabbit-HRP, at 1:20,000 for one hour at room 
temperature followed by three washes with TBS-T, five minutes each. Blots were then 
exposed to the substrate (GE Healthcare) for approximately 1-2 minutes before film 
detection was done, both of which were done in the dark room. Our co-IP and western 
blot experiments using Cripto-3 FLAG and the various tagged Lefty constructs were 
performed three times. 
4.7 In situ hybridization 
 Embryos were injected as described above. Controls and injected were de-
vitellinated at stage 10 and allowed to develop until gastrulation or neurulation in 1/3 
MMR. The dehydration step that preserves the embryos for in situ hybridisation involves 
fixing for two hours in MEMFA (MOPS, EGTA, MgSO4, formaldehyde) followed by 1-2 
washes in ethanol. Before fixation, stage 12 embryos required an additional step of 
making a small opening in the blastocoel to prevent entrapment of probes. All labware 
was treated w/ RNAse-ZAP (Ambion) to prevent RNA degradation, and formamide 
(Fisher) was deionized and stored at 4ºC. Formamide was used to decrease the probes’ 
annealing temperature. 
 Embryos were rehydrated by washing for five minutes in 75% methanol + 25% 
H2O, 50% methanol + 50% H2O, 25% methanol + 75% PBS-T, and finally with 100% 
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PBS-T. Using 10µg/ml of proteinase K, embryos were permeabilized for 20 minutes at 
room temperature (RT).  Washing twice with 0.1M triethanolamine for five minutes 
followed, and 125µl of acetic anhydride was added after the second wash to further 
decrease background. The embryos were then refixed for 20 minutes in PBS-T + 4% 
paraformaldehyde and washed twice in PBS-T, three minutes each. Prehybridization was 
done using “cheap-hyb” (lacking CHAPS, Heparin, and yeast RNA) for six hours at 
60ºC. Fresh hybridization buffer (50% formamide, 5X SSC pH 7.4, 1X Denhardt’s 
solution, 0.1% Tween 20, 5mM EDTA, 0.1% CHAPS, 100µg/ml Heparin, 1mg/ml yeast 
RNA, H2O) with 0.5µg/ml of probe was incubated with the embryos overnight at 60ºC in 
a H2O bath with gentle rocking. The “cheap-hyb” used in prehybridization step, the 
hybridization buffer for the probes, as well as the probes were stored at -20ºC. 
 The next day, embryos were rinsed in “cheap-hyb” for 10 minutes at 60ºC, 
followed by 20 minutes in 2X SSC, done three times. To eliminate any unhybridized or 
poorly hybridized probes, 20µg/ml RNase A and 10ug/ml RNase T1 were added to 50ml 
2X SSC and a thirty minute incubation at 37ºC was done. Excess probes were removed 
by washing for ten minutes in 2X SSC at RT, then twice for thirty minutes in 0.2X SSC 
at 60ºC. The embryos were then washed for ten minutes total in 1X MAB before 
blocking in MAB with 2% BMB reagent (Roche) for one hour at RT. Affinity-purified 
anti-DIG antibody (Roche) in MAB + 2% BMB reagent replaced the blocking solution 
for an overnight incubation at 4ºC with gentle nutation. The antibody was stored in 4ºC 
after this step for future use. The samples were then washed five times for 1 hour with 1X 
MAB to decrease background. The final wash was done overnight at 4ºC. 
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 The detection step started with two 5-minute washes at RT with alkaline 
phosphatase buffer, followed by fresh alkaline phosphatase buffer with 4.5µl/ml of NBT 
and 3.4µl/ml BCIP. The embryos were examined under the microscope every 30-45 
minutes depending on the probe, but they were otherwise kept in the dark to prevent the 
chemical reaction from occurring too quickly and causing over-staining. Embryos were 
fixed using PBS-T with 4% paraformaldehyde, nutated at 4ºC overnight in glass vials. 
They were rinsed three times for 5 minutes each in PBS-T the next day and finally stored 
in fresh PBST-T at 4ºC. For best storage, the vials are protected from light using 
aluminum foil. 
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Nodal, a Transforming Growth Factor-β (TGF-B), is a key regulator of proper 
development along with its atypical TGF-B inhibitor Lefty and its EGF-CFC co-receptor 
Cripto. Studies have shown that Nodal is unable to signal in the absence of a functional 
Cripto, indicating that it is a Nodal obligate co-receptor. In fact, one of the ways that 
Lefty prevents Nodal is by binding to Cripto and another way is through directly 
interacting with Nodal.  
 To characterize the regions of Xenopus Lefty (Xlefty) that molecularly interact 
with Nodal and XCr1, we created truncated, as well as uncleavable, Xlefty mutants and 
utilize them in phenotypic and biochemical experiments. We found that the M1 domain 
of Xlefty is not only the region that interacts with XCr1, but it is also sufficient to inhibit 
Nodal signaling. Furthermore, previous literature suggested that the mature form of 
Xlefty blocks Nodal. That means that the cleavage of Xlefty is necessary for Nodal 
inhibition. We believe our results are the first to show that only mature Xlefty interacts 
with Cripto. Processing of Xlefty at its first cleavage site is a requirement for Nodal 
inhibition, yet it has been implied that the second cleavage site is unimportant to its role 
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in embryogenesis. Our results show otherwise. In fact, it may play a crucial role in the 
folding and processing of Xlefty as its mutation led to a mature form that is unable to 
bind XCr1. Finally, we found that overexpression of XCr1 and one of the Xlefty 
truncations, Xlefty∆M2/M3, led to a phenotype in which embryos were unable to 
complete their blastopore closure. Perhaps the most affected structure was the notochord. 
While it can still form as long as germ layer cells differentiate into dorsal mesoderm, 
proper “zipping” of the notochord requires dorsal closure by convergent extension, which 
is one of the main cellular movements that occur during gastrulation. To our knowledge, 
this is a novel phenotype of XCr1 overexpression. This phenotype implies that XCr1 
plays a crucial role in mesoderm differentiation and convergent extension during early 
development. 
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